26/07/2026
松﨑医師が大学院で行った、膠芽腫に対するベバシズマブ治療が異常血管に及ぼす影響を組織学的に探索した研究がBrain Tumor Pathology誌に掲載されました。
おめでとうございます!
Glioblastoma (GBM) is a highly lethal brain tumor resistant to immunotherapy such as immune checkpoint inhibitors, partly because of an immunosuppressive tumor microenvironment and blood–brain barrier (BBB) dysfunction. Although bevacizumab can remodel the tumor vasculature, the relationship betwe...